SCHEMBL1950808

SCHEMBL1950808

CN1Cc2cc(-c3cccc(C(F)(F)F)c3)ccc2C(C)(Cc2cc(F)cc(F)c2)C1=O

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ASIC3 Q9UHC3 1/20 0.39
▸ BACE1 P56817 4/20 0.39
▸ CTSD P07339 1/20 0.39
▸ HRH3 Q9Y5N1 1/20 0.39
▸ PARP10 Q53GL7 1/20 0.38
▸ PARP11 Q9NR21 1/20 0.38
▸ GRIN1 Q05586 4/20 0.36
▸ GRIN2B Q13224 4/20 0.36
▸ S1PR5 Q9H228 1/20 0.35
▸ LIPG Q9Y5X9 1/20 0.35
▸ MAOB P27338 2/20 0.34
▸ NAAA Q02083 1/20 0.34
▸ RORC P51449 1/20 0.34
▸ KDM1A O60341 1/20 0.34
▸ MAOA P21397 1/20 0.34
▸ PIM1 P11309 1/20 0.34
▸ PIM2 Q9P1W9 1/20 0.34
▸ OPRM1 P35372 1/20 0.33
▸ OPRK1 P41145 1/20 0.33
▸ OPRL1 P41146 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1949510 0.93 BACE1 (0.41) ASIC3BACE1CTSDHRH3PARP10
SCHEMBL1949391 0.83 HTR7 (0.35) BACE1CTSDHRH3GRIN1GRIN2B
SCHEMBL2812633 0.81 BACE1 (0.42) BACE1CTSDPARP10PARP11GRIN1
SCHEMBL1951405 0.76 PARP10 (0.43) ASIC3BACE1CTSDPARP10PARP11
SCHEMBL3020986 0.74 PGR (0.55) —
SCHEMBL3031160 0.74 SLC6A7 (0.38) BACE1CTSDGRIN1GRIN2B
SCHEMBL3037745 0.74 GRIN1 (0.39) BACE1CTSDGRIN1GRIN2B
SCHEMBL3040774 0.73 GRIN1 (0.40) BACE1CTSDGRIN1GRIN2B
SCHEMBL2785547 0.72 SLC11A2 (0.44) BACE1CTSDGRIN1GRIN2B
SCHEMBL3021656 0.72 GRIN1 (0.45) BACE1CTSDGRIN1GRIN2B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20110136842-A1 Substituted Dihydroisoquinolinone and Isoquinolinedione Derivatives as Calcium Channel Blockers MERCK SHARP & DOHME CORP. 2011-06-09 — — US claimed
US-20110136842-A1 Substituted Dihydroisoquinolinone and Isoquinolinedione Derivatives as Calcium Channel Blockers MERCK SHARP & DOHME CORP. 2011-06-09 — — US disclosed
US-20110136842-A1 Substituted Dihydroisoquinolinone and Isoquinolinedione Derivatives as Calcium Channel Blockers MERCK SHARP & DOHME CORP. 2011-06-09 — — US disclosed
US-20110136842-A1 Substituted Dihydroisoquinolinone and Isoquinolinedione Derivatives as Calcium Channel Blockers MERCK SHARP & DOHME CORP. 2011-06-09 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110136842-A1 Substituted Dihydroisoquinolinone and Isoquinolinedione Derivatives as Calcium Channel Blockers CACNA1D, TRPV1, CACNA1S ASIC3 68/4885BACE1 196/4885CTSD 548/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback